Related Experiment Videos
[Classification of mild cognitive impairment in a population study]
1Alzeheimer's disease Research Center, Departamento de Neurologia y Psiquiatría, University of Pittsburgh, Facultad de Medicina, Pittsburgh, PA 15261, USA. lopezol@msx.upmc.edu
Revista De Neurologia
|August 26, 2003
Summary
Mild cognitive impairment (MCI) affects up to 22% of individuals aged 75 and older. This condition presents as either purely memory-related issues or broader cognitive deficits.
Area of Science:
- Neurology
- Gerontology
- Cognitive Science
Context:
- The Cardiovascular Health Study Cognition Study (CHS CS) is a large-scale epidemiological study examining cognitive health in older adults.
- Understanding the prevalence and subtypes of mild cognitive impairment (MCI) is crucial for identifying individuals at risk for dementia.
Purpose:
- To detail the diagnostic methodology for identifying mild cognitive impairment (MCI) within the CHS CS.
- To establish criteria for classifying different subtypes of MCI based on cognitive deficits.
Summary:
- The CHS CS utilized comprehensive neurological, neuropsychological, neuroradiological, and psychiatric assessments in 3602 participants to diagnose dementia and MCI.
- Mild cognitive impairment (MCI) was classified into Amnestic type (memory deficits) and Multiple Cognitive Deficits type (impairments in memory or other cognitive domains).
- The study found that up to 22% of participants aged 75 and older met the criteria for MCI, presenting in amnestic or broader cognitive deficit forms.
Impact:
- This methodology provides a standardized approach for diagnosing MCI in large cohort studies.
- The findings highlight the significant prevalence of MCI in older populations and its diverse clinical presentations.
- Accurate MCI diagnosis is essential for early intervention and potential prevention of dementia progression.